PCSK9 and hyperthyroidism: Bonde et al. reported that both eprotirome and hyperthyroidism reduced concentrations of Lp(a), PCSK9, plasma cholesterol in all lipoprotein fractions, apoB and apoA-I, while cholesterol synthesis was stable [111].